IDEAS home Printed from https://ideas.repec.org/h/spr/mgmchp/978-3-030-02363-8_33.html
   My bibliography  Save this book chapter

Bayer’s Acquisition of Monsanto

In: Wealth Creation in the World’s Largest Mergers and Acquisitions

Author

Listed:
  • B. Rajesh Kumar

    (Institute of Management Technology)

Abstract

Agriculture supply industry has witnessed consolidation with the three major mergers of which Monsanto–Bayer merger was the biggest. The other two mergers were DowDuPont and Syngenta–ChemChina mergers. In May 2016, Bayer the German pharmaceutical and drug company made an unsolicited offer to buy Monsanto, the US agrichemicals giant at $122, a share which was approximately valued at $66 billion at that time of the deal. The acquisition was aimed to boost agriculture research and innovation for doubling the world’s food supply by 2050. The deal required approval from regulators in 30 countries. The deal was the largest overseas deal ever by a Germany company. It was also the largest all cash buy out on record. With the merger, Bayer became single biggest supplier of seeds and crop protection chemicals in the world. The two companies were very strong companies offering similar products and had strong R&D capabilities. Under the current system, it was stated that it takes approximately 10 years for a company to develop and get approval for a new herbicide. Similarly it takes the same time period to make a seed trait which responds to the new chemical. The merger would facilitate Bayer and Monsanto’s combined resources to develop the paired products in a shorter period of time. The merger gave a “first mover” advantage for Bayer–Monsanto to create the biggest platform which would facilitate Bayer–Monsanto to control the food value chain in terms of which pesticides to be used and which seeds to be planted. The acquisition created a leading integrated agriculture business with broad product portfolio to provide innovative solutions. Total synergies of approximately $1.5 billion after 3 years of merger were expected along with additional integrated benefits. The cumulative return for the entire period of 539 days surrounding the acquisition period (−5 to +531 day) for Bayer was approximately 6.72%. The cumulative return for Monsanto stock during the time window period 0 to +25-day period was approximately 19.50%.

Suggested Citation

  • B. Rajesh Kumar, 2019. "Bayer’s Acquisition of Monsanto," Management for Professionals, in: Wealth Creation in the World’s Largest Mergers and Acquisitions, chapter 33, pages 281-287, Springer.
    • Handle: RePEc:spr:mgmchp:978-3-030-02363-8_33
    DOI: 10.1007/978-3-030-02363-8_33
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:mgmchp:978-3-030-02363-8_33. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.